Notal Vision is a patient-centric ophthalmic remote monitoring services provider extending retinal disease monitoring from the clinic to the home, providing physicians with remote monitoring services to support their patient care between office visits. With a proven approach to home-based, self-operated diagnostics, AI-enabled data analysis, and patient engagement, we help preserve patients’ vision. The Notal Vision Monitoring Center is a remote, Medicare credentialed ophthalmic provider and the epicenter of patient engagement. Led by practicing ophthalmologists and supported by certified ophthalmic professionals, the Monitoring Center offers a comprehensive nationwide age-related macular degeneration (AMD) home monitoring service for referred patients. The ForeseeHome® AMD Monitoring Program helps physicians detect the conversion to wet AMD early, leading to earlier treatment intervention and better visual outcomes. Our Home OCT pipeline technology will provide patient-initiated retinal OCT scans to support the management of patients with neovascular retinal diseases, complementing existing in-office imaging and standard of care treatments as well as emerging longer acting drugs and drug delivery systems.
Location: United States, Virginia, Manassas
Employees: 51-200
Total raised: $85M
Founded date: 2000
Investors 2
| Date | Name | Website |
| - | Elron Vent... | elronventu... |
| - | Elron Elec... | elron.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 01.06.2021 | Series D | $60M | - |
| 12.12.2019 | - | $25M | - |
Mentions in press and media 10
| Date | Title | Description |
| 01.06.2021 | Notal Vision raises up to $60 million to support development of its Home OCT technology and commercial growth of its ForeseeHome AMD Monitoring Program | Manassas, VA, June 01, 2021 (GLOBE NEWSWIRE) -- Notal Vision, Inc., a privately held ophthalmic home monitoring services provider focused on early disease detection and treatment monitoring is pleased to announce the closing of a Series D f... |
| 01.06.2021 | Notal Vision raises $60 million to support development of its Home OCT technology | Notal Vision has announced the closing of a Series D financing round of up to $60 million co-led by Soleus Capital and the company’s majority shareholder Ganot Capital |
| 12.12.2019 | Notal Vision Raises $25M in Funding | Notal Vision, Inc., a Manassas, VA-based ophthalmic diagnostic services company focused on advancing eye care with precision medicine by extending disease management from the clinic to the home, raised $25m in funding. Backers included Gano... |
| 11.12.2019 | Notal Vision Raises $25M Round | Manassas, VA, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Notal Vision, Inc., a privately held ophthalmic diagnostic services company focused on advancing eye care with precision medicine by extending disease management from the clinic to the home, i... |
| 11.12.2019 | Top tech startup news for today, Wednesday, December 11, 2019 – Disney, Omega Funds, Perfect Day, LeanDNA, Zero Card, and Aeva | Good morning! Below are some of the top tech startup news for today, Wednesday, December 11, 2019. Disney+ passes 22 million downloads on mobile devices, says app tracking firm Apptopia. Disney, the world’s most popular amusement parks, fl... |
| 11.12.2019 | Notal Vision secures $25 million in recent funding round for ForeseeHome® and pipeline technologies | Ganot Capital shows continued commitment to company growth through investment |
| 11.12.2019 | Israeli healthtech startup Notal Vision secures $25M to provide better methods of detecting age-related macular degeneration | Notal Vision, a Tel-Aviv, Israel-based healthtech startup focused on advancing eye care with precision medicine by extending disease management from the clinic to the home, has raised $25 million in funding to support the commercial growth ... |
| 20.10.2014 | Foreseeing The Future: One Million Tests Recorded | AMD Home Monitoring Device Reaches Landmark Milestone CHANTILLY, Va.–(BUSINESS WIRE)–October 20, 2014– Notal Vision, Inc. recently recorded its one-millionth individual test on its ForeseeHome® AMD Monitoring System. The ForeseeHome AMD Mon... |
| 18.11.2013 | New NEI Study Finds Patients at High-Risk for Developing Neovascular Age-Related Macular Degeneration Benefit from Home Monitoring for Early Detection of CNV | HOME Study Saves Vision ST. LOUIS–(BUSINESS WIRE)–November 18, 2013– The results of the Home Monitoring of the Eye (HOME) study, a subset of the Age-Related Eye Disease Study 2 (AREDS2) clinical centers* was presented last week at the annua... |
| 15.11.2013 | NIH Study Finds Patients at High-Risk for Developing Neovascular Age-Related Macular Degeneration Benefit from ForeseeHome Monitoring for Early Detection of CNV | Report Represents the Most Comprehensive Study of Home Monitoring for Progression of AMD ST. LOUIS–(BUSINESS WIRE)–November 16, 2013– The results of the Home Monitoring of the Eye (HOME) study, conducted in Age-Related Eye Disease Study 2 (... |